Skip to main content
. 2020 Oct 14;9(10):696. doi: 10.3390/antibiotics9100696

Table 2.

PK parameters attained and targeted values (represented by parenthesis) in the PK/PD model.

Parameter DAL VAN DAP CFZ
fCmax (mg/L) 30.1 ± 0.018 (30.1) 34.9 ± 0.76 (36.0) 13.95 ± 0.04 (14.1) 27.55 ± 0.91 (26.0)
T1/2 (h) 184 ± 0.01 (187.40) 6.6 ± 0.03 (6.00) 7.6 ± 0.07 (8.00) 2.4 ± 0.04 (2.3)
AUC (mg × h/mL) or T > MIC (h) 7255± 0.03 324. 66 ± 1.3 192.6 ± 0.09 0.00
fAUC/MIC 58,040 (D712)
50,040 (6913)
81
(D712)
40
(6913)
96
(D712)
49
(6913)
234,082 (DAL+CFZ D712); 646 (VAN+CFZ; D712); 1541( DAP+CFZ; D712); 234,082 (DAL+CFZ; 6913)
323 (VAN+CFZ; 6913); 385 (DAP+CFZ; 6913)

Represented in Table 2 are the PK parameters attained in the in-vitro one-compartment models.